1. Home
  2. CDXC vs CURV Comparison

CDXC vs CURV Comparison

Compare CDXC & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXC
  • CURV
  • Stock Information
  • Founded
  • CDXC 1999
  • CURV 2001
  • Country
  • CDXC United States
  • CURV United States
  • Employees
  • CDXC N/A
  • CURV N/A
  • Industry
  • CDXC Medicinal Chemicals and Botanical Products
  • CURV Clothing/Shoe/Accessory Stores
  • Sector
  • CDXC Health Care
  • CURV Consumer Discretionary
  • Exchange
  • CDXC Nasdaq
  • CURV Nasdaq
  • Market Cap
  • CDXC 415.5M
  • CURV 402.0M
  • IPO Year
  • CDXC N/A
  • CURV 2021
  • Fundamental
  • Price
  • CDXC $5.48
  • CURV $5.26
  • Analyst Decision
  • CDXC Strong Buy
  • CURV Hold
  • Analyst Count
  • CDXC 2
  • CURV 5
  • Target Price
  • CDXC $8.00
  • CURV $5.25
  • AVG Volume (30 Days)
  • CDXC 587.4K
  • CURV 818.6K
  • Earning Date
  • CDXC 10-31-2024
  • CURV 12-03-2024
  • Dividend Yield
  • CDXC N/A
  • CURV N/A
  • EPS Growth
  • CDXC N/A
  • CURV 29.45
  • EPS
  • CDXC 0.02
  • CURV 0.14
  • Revenue
  • CDXC $91,668,000.00
  • CURV $1,121,714,000.00
  • Revenue This Year
  • CDXC $18.64
  • CURV N/A
  • Revenue Next Year
  • CDXC $20.72
  • CURV $0.80
  • P/E Ratio
  • CDXC $274.95
  • CURV $36.81
  • Revenue Growth
  • CDXC 9.95
  • CURV N/A
  • 52 Week Low
  • CDXC $1.36
  • CURV $2.18
  • 52 Week High
  • CDXC $7.97
  • CURV $9.14
  • Technical
  • Relative Strength Index (RSI)
  • CDXC 39.30
  • CURV 66.58
  • Support Level
  • CDXC $5.26
  • CURV $5.01
  • Resistance Level
  • CDXC $5.56
  • CURV $5.43
  • Average True Range (ATR)
  • CDXC 0.29
  • CURV 0.36
  • MACD
  • CDXC -0.09
  • CURV 0.07
  • Stochastic Oscillator
  • CDXC 18.88
  • CURV 75.52

About CDXC ChromaDex Corporation

ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.

About CURV Torrid Holdings Inc.

Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America targeting 27 to 42-year-old women. It is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of e-Commerce platform and stores.

Share on Social Networks: